These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2548866)

  • 1. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE; Hagelbäck A
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):946-9. PubMed ID: 1486894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing of anaerobic bacteria.
    Finegold SM; Rolfe RD
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):33-40. PubMed ID: 6323094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of anaerobic bacteria to meropenem.
    Nord CE; Lindmark A; Persson I
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of the new oral cephalosporin Bay v 3522 against aerobic and anaerobic bacteria.
    Rylander M; Nord CE; Norrby SR
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):777-82. PubMed ID: 2261923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria.
    Shadomy S; Mayhall CG; Apollo E
    J Infect Dis; 1977 Nov; 136(5):697-700. PubMed ID: 915342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of cefcanel and some other cephalosporins against Pasteurella multocida.
    Holst E; Rollof J; Miörner H
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2142-3. PubMed ID: 2619280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of cefcanel.
    Bergan T; da Fonseca J
    Chemotherapy; 1993; 39(2):96-104. PubMed ID: 8458252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
    Wexler H; Carter WT; Harris B; Finegold SM
    Antimicrob Agents Chemother; 1984 Feb; 25(2):162-4. PubMed ID: 6712200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
    Wells CL; Wilkins TD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.